2023年3月19日 · 2016年6月24日美国放射学员发布超声造影LI-RADS（ACR CEUS LI-RADS）指南,将肝脏结节的超声造影特征将其分为5类，即CEUS LR 1类——CEUS LR 5类，另外还有LR-5V及CEUS LR-M类，其各自代表的意义及诊断标准在下文中一一详述：

LI-RADS® was created to standardize the reporting and data collection of CT and MR imaging for hepatocellular carcinoma. This method of categorizing liver findings for patients with risk …

The Liver Imaging Reporting and Data System (LI-RADS) is a classification system for liver lesions which is used in patients with liver cirrhosis and chronic HBV without cirrhosis, because these patients have an increased risk of hepatocellular carcinoma (HCC).

LR-M is intended to preserve the specificity of the LI-RADS algorithm for diagnosis of HCC while not losing sensitivity for diagnosis of malignancy. The purpose of this paper is to provide a brief background on LR-M, discuss the diagnostic criteria new to v2017, special considerations for its application, and management implications.

2024年7月26日 · Liver Imaging Reporting and Data System (LI-RADS) is a standardized terminology and classification system for imaging findings in liver lesions. A liver lesion's LI-RADS score indicates its relative risk for hepatocellular carcinoma (HCC).

2024年4月27日 · CT/MRI Liver Imaging Reporting and Data System (LI-RADS) is an algorithm for diagnosing and staging hepatocellular carcinoma (HCC) (CT/MRI Diagnostic LI-RADS) or assessing the response of HCC to locoregional treatment (CT/MRI Treatment Response LI-RADS) using CT or MRI with extracellular contrast agents or …

2024年8月28日 · The Contrast-enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) is a standardized classification system, algorithm, and terminology for diagnosing hepatocellular carcinoma (HCC) in high-risk patients using CEUS with blood-...

2020年6月9日 · 肝脏影像报告及数据系统（LI-RADS）是一个由美国放射学院（ACR）发布的肝脏影像检查规范及诊断分类系统，对肝细胞癌（HCC）高风险人群的影像检查技术、征象描述术语、诊断报告及数据收集进行了详细介绍和规范化要求。

The LI‐RADS categories suggestive of malignancy include LR‐4 (probably HCC), LR‐5 (definitely HCC), LR‐M (probably or definitely malignant, not specific for HCC), and LR‐TIV (malignancy with tumor in vein).

2025年3月11日 · US is the first-line modality for HCC surveillance in all regions of the world (10 – 12). Despite being the most used modality in this setting, a standardized approach to the interpretation and reporting of US findings was not attempted until 2017, when the US Liver Imaging Reporting and Data System (LI-RADS) algorithm was introduced (13, 14).